Komal is a Staff Scientist at the Gene Editing Institute (GEI). She contributes to the translational group’s efforts for the pre-Investigational New Drug (IND) for the treatment of lung cancer. She received her Bachelor of Science in Biomedical Research from Delaware State University. Prior to joining GEI, she was part of Charles River’s R&D team where she developed the filamentous fungi assay to identify fungi using MALDI-TOF mass spectrometry. She was also an integral part of the efforts to develop the Accugenix® MALDI Library database for bacteria, yeasts, and filamentous fungi. She evaluated and developed potential microbial identification products and services. Her experience includes MALDI-TOF mass spectrometry, spectroscopy, Sanger sequencing and Next-Generation Sequencing. She’s also worked at Delaware State University’s neurodegeneration lab as a research assistant to identify a potential drug lead for treating frontotemporal dementia (FTD).
